| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1082842603 |
| P356 | DOI | 10.1007/BF03401579 |
| P932 | PMC publication ID | 2229996 |
| P698 | PubMed publication ID | 8521299 |
| P2093 | author name string | C Tomasetto | |
| M C Rio | |||
| P Basset | |||
| J A Byrne | |||
| J P Bellocq | |||
| N Rouyer | |||
| P2860 | cites work | Molecular characterization and expression of the gene encoding human erythroid-potentiating activity | Q24299977 |
| A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas | Q28116420 | ||
| Expression of TIMP3 mRNA is elevated in retinas affected by simplex retinitis pigmentosa | Q28118195 | ||
| Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing | Q28131793 | ||
| Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy | Q28236562 | ||
| A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence | Q28245184 | ||
| Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family | Q28252355 | ||
| Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family | Q28252820 | ||
| Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22 | Q28253848 | ||
| Tumor cell interactions with the extracellular matrix during invasion and metastasis | Q28258256 | ||
| Cloning and characterization of human tissue inhibitor of metalloproteinases-3 | Q28302568 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases | Q33900001 | ||
| The biochemistry of 3'-end cleavage and polyadenylation of messenger RNA precursors. | Q34243656 | ||
| Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas | Q34497741 | ||
| Mechanisms of placental invasion of the uterus and their control | Q35218621 | ||
| Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal | Q35228128 | ||
| The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases | Q35301529 | ||
| The matrix-degrading metalloproteinases | Q35535244 | ||
| Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line | Q35726298 | ||
| Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia | Q35831955 | ||
| Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro | Q35880505 | ||
| Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression | Q36135363 | ||
| Cell-type-specific cDNA probes and the murine I region: the localization and orientation of Ad alpha | Q36267148 | ||
| Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3. | Q36743395 | ||
| Matrix metalloproteinases and their inhibitors in connective tissue remodeling | Q37174661 | ||
| Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin | Q37234490 | ||
| Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts | Q37292630 | ||
| A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family | Q38326523 | ||
| Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines | Q40449823 | ||
| Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions | Q40815243 | ||
| Biology and biochemistry of proteinases in tumor invasion. | Q40868702 | ||
| Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum | Q41639433 | ||
| Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues | Q42603394 | ||
| Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10. | Q48081432 | ||
| Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. | Q52517085 | ||
| Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity | Q67531378 | ||
| Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferation | Q72102660 | ||
| Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas | Q72760388 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast carcinoma | Q18555947 |
| P304 | page(s) | 418-427 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: identification of multiple polyadenylation sites and a stromal pattern of expression | |
| P478 | volume | 1 |
| Q28185858 | A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 |
| Q35605873 | Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome |
| Q42280122 | Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. |
| Q46257564 | Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness |
| Q41239245 | Matrix metalloproteinases and the development of cancer |
| Q41460667 | Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications |
| Q33922875 | New paradigms for the treatment of cancer: the role of anti-angiogenesis agents |
| Q34577446 | Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression. |
| Q30493907 | Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts |
| Q22009080 | Preliminary characterization of the protein encoded by human testis-enhanced gene transcript (TEGT) |
| Q33962794 | Stromelysin-3 in the biology of the normal and neoplastic mammary gland. |
| Q40162313 | TIMP-3 and Phosphatidylinositol 3-kinase genes were found to be related to the progression of colon cancer in a comparison of pneumoperitoneum and laparotomy in a murine model |
| Q36421730 | TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma |
Search more.